Skip to main content
. 2022 Jan 30;36(1):11–20. doi: 10.1007/s40290-021-00417-5
Messenger RNA (mRNA) has immense therapeutic potential in infectious diseases and cancer immunotherapy.
Clinically successful lipid nanoparticles (LNPs) are smart nano-sized lipid-based carrier systems for mRNA delivery into the cytosol.
Engineering cationic ionizable lipids of LNPs with a suitable acid dissociation constant (pKa) for enhanced complexation and subsequent endosomal release is being actively researched.
There is a specific need to enhance the storage stability of LNP-mRNA vaccines to above 0 °C to bring these lifesaving vaccines to the developing world.